Veterinary Medicine Information website

Nobivac Tricat Trio, liofilizat i otapalo za suspenziju za injekciju, za mačke

Authorised
  • Feline panleucopenia virus, strain MW-1, Live
  • Felid herpesvirus 1, strain G2620A, Live
  • Feline calicivirus, strain F9, Live

Product identification

Medicine name:
Nobivac Tricat Trio, liofilizat i otapalo za suspenziju za injekciju, za mačke
Active substance:
  • Feline panleucopenia virus, strain MW-1, Live
  • Felid herpesvirus 1, strain G2620A, Live
  • Feline calicivirus, strain F9, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline panleucopenia virus, strain MW-1, Live
    4.30
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Felid herpesvirus 1, strain G2620A, Live
    5.20
    log10 plaque forming unit(s)
    /
    1.00
    millilitre(s)
  • Feline calicivirus, strain F9, Live
    4.60
    log10 plaque forming unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD04
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Available in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V. Subsidiary In The Republic Of Croatia
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/13-01/563
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 21/06/2023
Updated on: 26/06/2023